Riskpilot← Back to searchSign inGet full accessDOKTOR NOVA AS
ASActiveOrg 928966186Heggvegen 19, 2322 RidabuGeneral medical practice activities · NACE 8621Est. 20221 employees
Revenue 2025
NOK 3,9M
0% vs 2024
EBITDA margin
38.8%
-12% vs 2024
Equity ratio
10.4%
Financial strength
Net profit 2025
NOK 1,2M
-11% vs 2024
| Revenue | NOK 3,9M | +0% |
| EBITDA | NOK 1,5M | -12% |
| Net profit | NOK 1,2M | -11% |
| Total assets | NOK 2M | -9% |
| Equity | NOK 210K | +3% |
| Employees | 1 | — |
Legal name
DOKTOR NOVA AS
Org number
928966186
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
22. mars 2022
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Medisinsk behandling, kurs-, foredrags- og undervisningsvirksomhet, utarbeidelse av spesialisterklæringer og sakkyndige oppdrag, konsulentvirksomhet og forvaltning av selskapets kapital og ressurser i form av investeringsvirksomhet, deltakelse i andre selskaper, finansforvaltning, kjøp, drift, oppføring og rehabilitering av fast eiendom.
Address
Heggvegen 19, 2322 Ridabu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 3 402 | 3 540 | 3 903 | 3 901 |
| Staff expenses | −1 168 | −1 077 | −1 210 | −1 272 |
| EBITDA | 1 187 | 1 451 | 1 718 | 1 515 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | 1 187 | 1 451 | 1 718 | 1 515 |
| Net financials | −0 | 10 | 28 | 31 |
| Profit before tax | 1 187 | 1 461 | 1 746 | 1 546 |
| Tax | 264 | 321 | 384 | 340 |
| Net profit | 923 | 1 140 | 1 362 | 1 205 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 1 468 | 1 760 | 2 228 | 2 027 |
| Equity | 53 | 193 | 205 | 210 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 1 415 | 1 567 | 2 023 | 1 816 |
| Total debt | 1 415 | 1 567 | 2 023 | 1 816 |
EBITDA margin
38.8%
This company
15.8%
Market median
+146% vs market
20222025
Equity ratio
10.4%
This company
38.2%
Market median
-73% vs market
20222025
Return on equity
573.2%
This company
18.4%
Market median
+3015% vs market
20222025
Net profit margin
30.9%
This company
8.1%
Market median
+281% vs market
20222025
Asset turnover
1.92×
This company
1.12×
Market median
+71% vs market
20222025
Debt / equity
8.64×
This company
0.62×
Market median
-1294% vs market
20222025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KS Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Kos As
DOKTOR NOVA AS Board members of DOKTOR NOVA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl-Otto Sørensen | Chief Executive Officer | 0 companies |
| Maria Elisabeth Alvenes | Board of Directors | 0 companies |